New research undertaken by researchers at the University of Edinburgh’s Usher Institute, has confirmed that a first booster dose reduced the risk of severe COVID-19 during the Omicron wave.
The nasal spray vaccine being developed by scientists at Oxford University only triggers mucosal antibody responses in a minority of people, according to the first data available from its phase 1 clinical trial.
The COV-AD consortium has published new findings showing that people with compromised or suppressed immune systems are still at higher risk of poor outcomes from COVID-19 compared to the general population.
The National Core Studies Immunity (NCSi) Programme and the UK Coronavirus Immunology Consortium (UK-CIC) are pleased to present the following free public webinar: 'COVID-19 vaccines, boosters and immunity’ on Tuesday 27 September.
A number of organisations have urged pregnant women to get vaccinated and take up their boosters, after misinformation about a change in guidance was spread widely on social media channels.
The team behind the development of the Oxford-AstraZeneca COVID-19 vaccine has been awarded the Royal Society’s Copley Medal – the first time in the award’s nearly 300-year history that it has been awarded to a whole team rather than an individual.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new updated version of the Moderna COVID-19 vaccine that targets both the original variant of the virus and Omicron, the variant now circulating worldwide.